Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,651   4.84  Index Moved Down -0.29%
IDXX NEOG ABAX VIVO Manufacturing Apparel Large Value Macroaxis 20 
United States GSPC USD ...  |  Optimize Portfolios


Processing
Collecting data for NEOG

Neogen quote and profile

 
 Companies |  Insiders  | Dashboard  
     
54.63
  
STOCK
0.29  Macroaxis: 0.53 Up   0.53%  
Year To Date
37.0655.38
Last 1 Month(s)
49.7255.38
Trading Day 
53.4154.63
May 23 2013 

Diversification Suggestion

Use Neogen to enhance returns of your portfolios. The stock experiences moderate upward volatility
Analyze Neogen Corp Trend or Check current 30 days Neogen correlation with market (S&P 500)
1 Month Beta 1.65  
Highest Price:  
Lowest Price:  
55.38  
49.72  
May 21 2013 
April 26 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Neogen will likely underperform.
Neogen Corp Large BetaNeogen Corp Beta Legend
NEOG United States Nasdaq
Neogen Corp
Healthcare
Diagnostic Substances
Benchmark S&P 500
http://www.neogen.com
Contact Number: 517. 372. 9200
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation1.11 B
Shares Outstanding23.92 M
Number of Shares Shorted1.19 M
Revenue200.07 M
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 thisGreen NEOG NEOG agains markets  0.53 % Macroaxis: 0.53 Moved Up  
 
 United States Russel   0.21 % Macroaxis: 0.21 Moved Up  
 
 United States SP 500   0.29 % Macroaxis: 0.29 Moved Down  
 
 United States NYSE   0.44 % Macroaxis: 0.44 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Neogen Leadership

James Herbert Chairman and CEO
Joseph Madden Vice President - Scientific Affairs
Kenneth Kodilla Vice President - Manufacturing
Lon Bohannon President, COO and Director, CPA

Neogen Price and Market Media

The median price of Neogen for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 52.92 with a coefficient of variation of 3.56. The daily time series for the period is distributed with a sample standard deviation of 1.87, arithmetic mean of 52.49, and mean deviation of 1.54. The Stock received substential amount of media coverage during this period.
Neogen         SP 500
Price Growth (%)
 
1
Food Safety Diagnostics The World Market04/24/2013Macroaxis: News
2
NEOGEN CORPORATION Neogen introduces meat species identifica...04/26/2013Macroaxis: News
3
Neogen Launches Comprehensive Cattle Genomic Test Daily Mark...05/07/2013Macroaxis: News
4
NEOGEN CORPORATION Neogen Soleris yeast and mold test now AO...05/09/2013Macroaxis: News

Neogen Summary

Neogen Corp [NEOG] is traded on NASDAQ in USA. It is located in Lansing, MI and employs 746 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.24 B. Neogen Corp conducts business under Healthcare sector and is part of Diagnostic Substances industry. This company has 23.92 M outstanding shares of which 1.19 M shares are now shorted by private and institutional investors with about 15.1 trading days to cover.
Neogen Corporationration, together with its subsidiaries, develops, manufactures, and markets various solutions for food and animal safety worldwide. more
Past Market
Over 30
Days
16
Out Of
100
 
Chance of
Less
Than
29 %
 
Follow Neogen with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Neogen to your reader
 

Neogen Research Report

Neogen vs. IDEXX

Correlation analysis and fundamentals comparison between Neogen Corp and IDEXX Laboratories

Neogen Executives

Steven Quinlan CFO, Principal Accounting Officer, VP and Secretary

Neogen Directors

A Fischer Independent Director
Thomas Reed Independent Director
G Papesh Independent Director
Richard Crowder Independent Director
William Boehm Independent Director

Neogen Management

Richard Current Secretary

Neogen Fundamentals

Shares Owned by Institutions vs Retained Earnings
Price to Book vs Revenue
Shares Owned by Institutions vs Beta
Profit Margin vs Revenue

Neogen vs Competition

Neogen vs. IDEXX Laboratories Inc
Neogen vs. Abaxis Inc
Neogen vs. Meridian Bioscience Inc
Neogen vs. Quidel Corp
Neogen vs. Synta Pharmaceuticals Corp
Neogen vs. AMAG Pharmaceuticals Inc
Neogen vs. SurModics Inc
Neogen vs. Trinity Biotech plc
Neogen vs. Nymox Pharmaceutical Corporation

Neogen May 23 2013 Opportunity Range

Downside Deviation0.9474
Information Ratio0.1308
Maximum Drawdown4.22
Value At Risk(1.41)
Potential Upside2.5

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium